NCT05057975

Brief Summary

Validation of an integrated digital solution (SUNrise®) of mandibular movement automatic analysis by artificial intelligence versus polysomnography for obstructive sleep apnea diagnosis: a prospective, randomized, parallel-arm, open-label, multicenter, national, controlled study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
848

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

19 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 27, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

October 28, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 7, 2024

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

2.9 years

First QC Date

August 27, 2021

Last Update Submit

December 5, 2024

Conditions

Keywords

polysomnographyobstructive sleep apneahome sleep testartificial intelligencemandibular movement

Outcome Measures

Primary Outcomes (4)

  • Change in daily sleepiness

    To determine the non-inferiority of Sunrise vs PSG on sleepiness at 3 months post-diagnosis using the Epworth Sleepiness Scale (ESS) score. The ESS score (the sum of 8 item scores, 0-3) can range from 0 to 24. The higher the ESS score, the higher the average sleep propensity in daily life.

    3 months post-diagnosis

  • Time to diagnosis

    To determine the superiority of Sunrise vs PSG in terms of time between inclusion and diagnosis appointment

    Up to 12 months

  • Time to treatment

    To determine the superiority of Sunrise vs PSG in terms of time between inclusion and treatment initiation

    Up to 15 months

  • Change in daily sleepiness

    To determine the superiority of Sunrise vs PSG on sleepiness at 3 months post-inclusion using ESS

    3 months post inclusion

Secondary Outcomes (8)

  • Change in quality of life

    3 months post inclusion visit

  • Change in quality of life

    3 months post inclusion visit

  • Change in work productivity

    3 months post-inclusion

  • cost (€)/QALY

    3 months post-diagnosis

  • Net profit for the French social security

    estimated at 3 years

  • +3 more secondary outcomes

Study Arms (2)

Sunrise

EXPERIMENTAL

Home Sleep Test, OSA diagnosis based on mandibular movements recording

Device: Sunrise

PSG

ACTIVE COMPARATOR

Polysomnography, OSA diagnosis based on local scoring by center

Device: polysomnography

Interventions

SunriseDEVICE

Use of the Sunrise device for three nights to register mandibular movements that will be automatically analysed using artificial intelligence.

Sunrise

Reference protocol to diagnose OSA (in-lab or outpatient PSG)

PSG

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Man or woman aged between 18 to 80 years old
  • Patient referred for a suspicion of OSA
  • Patient having a smartphone and internet connection at home and able to use a mobile application
  • Patient affiliated to the social security system

You may not qualify if:

  • Patient suffering from severe chronic obstructive or restrictive pulmonary disease with or without oxygen at the discretion of the investigator
  • Patient refusing to shave his beard that could prevent him to wear the device on the chin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

CHU Angers

Angers, 49933, France

Location

Hôpitaux Universitaires de Paris Seine Saint-Denis (HUPSSD, AP-HP),

Bobigny, 93000, France

Location

Nouvelle clinique Bel-Air

Bordeaux, 33073, France

Location

CHU Bordeaux - Hôpital Pellegrin

Bordeaux, 33076, France

Location

AP-HP Hôpital Henri Mondor

Créteil, 94000, France

Location

Chu Grenoble Alpes,

Grenoble, 38043, France

Location

CHRU Lille - Hôpital Roger Salengro

Lille, 59037, France

Location

Hôpital privé la Louvière

Lille, 59800, France

Location

CHU Lyon - Hôpital de la Croix-Rousse

Lyon, 69004, France

Location

Hôpital Européen Marseille

Marseille, 13003, France

Location

CHU Montpellier - Hôpital Gui-de-Chauliac

Montpellier, 34295, France

Location

CHRU de Nancy - Hôpital d'Adultes de Brabois

Nancy, 54500, France

Location

AP-HP Pitié Salpêtrière

Paris, 75013, France

Location

AP-HP Hôpital Bichat-Claude Bernard

Paris, 75018, France

Location

AP-HP CUP Hôpital Hôtel Dieu

Paris, 75181, France

Location

CHU de Reims - Hôpital Maison Blanche

Reims, 51092, France

Location

Polyclinique Saint-Laurent

Rennes, 35700, France

Location

Centre du Sommeil de Grenoble

Saint-Martin-d'Hères, 38400, France

Location

CHU de Toulouse - Hôpital Larrey

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Polysomnography

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Jean-Louis PEPIN, Pr

    CHU Grenoble Alpes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Prospective, controlled, randomized, parrallel, open label, multicenter and national
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2021

First Posted

September 27, 2021

Study Start

October 28, 2021

Primary Completion

October 7, 2024

Study Completion

October 7, 2024

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations